Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
Katharina Schwarze, James Buchanan, Jenny C. Taylor, et al.
Genetics in Medicine (2018) Vol. 20, Iss. 10, pp. 1122-1130
Open Access | Times Cited: 454

Showing 1-25 of 454 citing articles:

Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
Kandamurugu Manickam, Monica R. McClain, Laurie Demmer, et al.
Genetics in Medicine (2021) Vol. 23, Iss. 11, pp. 2029-2037
Open Access | Times Cited: 400
Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis
Bodhraj Acharya, Ashma Acharya, Sanjay S. Gautam, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 5, pp. 4065-4075
Closed Access | Times Cited: 203
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
Katharina Schwarze, James Buchanan, Jilles M Fermont, et al.
Genetics in Medicine (2019) Vol. 22, Iss. 1, pp. 85-94
Open Access | Times Cited: 194
Next-generation sequencing in Charcot–Marie–Tooth disease: opportunities and challenges
Menelaos Pipis, Alexander M. Rossor, Matilde Laurà, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 11, pp. 644-656
Closed Access | Times Cited: 189
Advancing Personalized Medicine Through the Application of Whole Exome Sequencing and Big Data Analytics
Pawel Suwinski, ChuangKee Ong, Maurice HT Ling, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 187
TMB or not TMB as a biomarker: That is the question
Alfredo Addeo, Alex Friedlaender, Giuseppe Luigi Banna, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 163, pp. 103374-103374
Closed Access | Times Cited: 177
Complexities in understanding antimicrobial resistance across domesticated animal, human, and environmental systems
David W. Graham, Gilles Bergeron, Megan W. Bourassa, et al.
Annals of the New York Academy of Sciences (2019) Vol. 1441, Iss. 1, pp. 17-30
Open Access | Times Cited: 172
Application of Next Generation Sequencing in Laboratory Medicine
Yiming Zhong, Feng Xu, Jinhua Wu, et al.
Annals of Laboratory Medicine (2020) Vol. 41, Iss. 1, pp. 25-43
Open Access | Times Cited: 160
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
Xiujing He, Xiaowei Liu, Fengli Zuo, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 187-200
Open Access | Times Cited: 156
Machine learning for multi-omics data integration in cancer
Zhaoxiang Cai, Rebecca C. Poulos, Jia Liu, et al.
iScience (2022) Vol. 25, Iss. 2, pp. 103798-103798
Open Access | Times Cited: 154
Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders
Bekim Sadiković, Michael A. Levy, Jennifer Kerkhof, et al.
Genetics in Medicine (2021) Vol. 23, Iss. 6, pp. 1065-1074
Open Access | Times Cited: 148
Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders
Michael A. Levy, Haley McConkey, Jennifer Kerkhof, et al.
Human Genetics and Genomics Advances (2021) Vol. 3, Iss. 1, pp. 100075-100075
Open Access | Times Cited: 119
Rare disease emerging as a global public health priority
Claudia Ching Yan Chung, Annie Chu, Brian Hon‐Yin Chung
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 78
Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis
Lisa Ewans, André E. Minoche, Deborah Schofield, et al.
European Journal of Human Genetics (2022) Vol. 30, Iss. 10, pp. 1121-1131
Open Access | Times Cited: 73
Targeted Sequencing Approach and Its Clinical Applications for the Molecular Diagnosis of Human Diseases
Xiao M. Pei, Martin Ho Yin Yeung, Alex Ngai Nick Wong, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 493-493
Open Access | Times Cited: 48
Pathogenomics and Management of Fusarium Diseases in Plants
Sephra N. Rampersad
Pathogens (2020) Vol. 9, Iss. 5, pp. 340-340
Open Access | Times Cited: 104
Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease
Holm H. Uhlig, Fabienne Charbit‐Henrion, Daniel Kotlarz, et al.
Journal of Pediatric Gastroenterology and Nutrition (2020) Vol. 72, Iss. 3, pp. 456-473
Open Access | Times Cited: 104
A population‐based cost‐effectiveness study of early genetic testing in severe epilepsies of infancy
Katherine B. Howell, Stefanie Eggers, Kim Dalziel, et al.
Epilepsia (2018) Vol. 59, Iss. 6, pp. 1177-1187
Open Access | Times Cited: 101
Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design
Simon Dagenais, Leo Russo, Ann Madsen, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 1, pp. 77-89
Open Access | Times Cited: 93
Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?
Zhichao Liu, Liyuan Zhu, Ruth Roberts, et al.
Trends in Genetics (2019) Vol. 35, Iss. 11, pp. 852-867
Open Access | Times Cited: 85
Impact of predictive, preventive and precision medicine strategies in epilepsy
Rima Nabbout, Mathieu Kuchenbuch
Nature Reviews Neurology (2020) Vol. 16, Iss. 12, pp. 674-688
Closed Access | Times Cited: 77
Unlocking the efficiency of genomics laboratories with robotic liquid-handling
Houriiyah Tegally, James Emmanuel San, Jennifer Giandhari, et al.
BMC Genomics (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 71
The clinical utility of exome and genome sequencing across clinical indications: a systematic review
Salma Shickh, Chloe Mighton, Elizabeth Uleryk, et al.
Human Genetics (2021) Vol. 140, Iss. 10, pp. 1403-1416
Closed Access | Times Cited: 71
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?
Giancarlo Pruneri, Filippo de Braud, Anna Sapino, et al.
PharmacoEconomics - Open (2021) Vol. 5, Iss. 2, pp. 285-298
Open Access | Times Cited: 60
Clinical utility of whole-genome sequencing in precision oncology
Richard Rosenquist, Edwin Cuppen, Reinhard Buettner, et al.
Seminars in Cancer Biology (2021) Vol. 84, pp. 32-39
Closed Access | Times Cited: 59
Page 1 - Next Page

Scroll to top